Edmond de Rothschild Holding’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,000
| Closed | -$8.76K | – | 706 |
|
|
2024
Q1 | $8.76K | Hold |
1,000
| – | – | ﹤0.01% | 635 |
|
|
2023
Q4 | $7.44K | Hold |
1,000
| – | – | ﹤0.01% | 652 |
|
|
2023
Q3 | $10K | Hold |
1,000
| – | – | ﹤0.01% | 654 |
|
|
2023
Q2 | $10.3K | Hold |
1,000
| – | – | ﹤0.01% | 676 |
|
|
2023
Q1 | $10.5K | Hold |
1,000
| – | – | ﹤0.01% | 683 |
|
|
2022
Q4 | $12.7K | Hold |
1,000
| – | – | ﹤0.01% | 735 |
|
|
2022
Q3 | $15K | Hold |
1,000
| – | – | ﹤0.01% | 753 |
|
|
2022
Q2 | $20K | Hold |
1,000
| – | – | ﹤0.01% | 729 |
|
|
2022
Q1 | $37K | Hold |
1,000
| – | – | ﹤0.01% | 703 |
|
|
2021
Q4 | $36K | Hold |
1,000
| – | – | ﹤0.01% | 732 |
|
|
2021
Q3 | $75K | Hold |
1,000
| – | – | ﹤0.01% | 656 |
|
|
2021
Q2 | $88K | Hold |
1,000
| – | – | ﹤0.01% | 620 |
|
|
2021
Q1 | $114K | Buy |
+1,000
| New | +$114K | ﹤0.01% | 546 |
|